These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


114 related items for PubMed ID: 1256547

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Antiviral activity of ribavirin on influenza infection in ferrets.
    Schofield KP, Potter CW, Edey D, Jennings R, Oxford JS.
    J Antimicrob Chemother; 1975 Dec; 1(4 Suppl):63-9. PubMed ID: 1206033
    [No Abstract] [Full Text] [Related]

  • 4. The effects of 1-beta-D ribofuranosyl-1, 2, 4-triazole-3-carboxamide (Ribavirin) on the transplanted tumours of animals.
    Newman H, Vodinelich L, Potter CW.
    Eur J Cancer (1965); 1977 Aug; 13(8):821-30. PubMed ID: 198214
    [No Abstract] [Full Text] [Related]

  • 5. Lack of suppression of resistance factors to influenza infections in mice pretreated with virazole.
    Huffman JH, Anderson MA, Allen LB, Sidwell RW.
    J Antimicrob Chemother; 1977 Jan; 3(1):79-85. PubMed ID: 845105
    [No Abstract] [Full Text] [Related]

  • 6. Therapeutic effects of ribavirin given by the intraperitoneal or aerosol route against influenza virus infections in mice.
    Stephen EL, Dominik JW, Moe JB, Walker JS.
    Antimicrob Agents Chemother; 1976 Sep; 10(3):549-54. PubMed ID: 984796
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy of ribavirin against influenza virus in tissue culture and in mice.
    Durr FE, Lindh HF.
    Ann N Y Acad Sci; 1975 Aug 08; 255():366-71. PubMed ID: 1059365
    [No Abstract] [Full Text] [Related]

  • 10. Dominant-negative mutants as antiviral agents: simultaneous infection with the cold-adapted live-virus vaccine for influenza A protects ferrets from disease produced by wild-type influenza A.
    Whitaker-Dowling P, Maassab HF, Youngner JS.
    J Infect Dis; 1991 Dec 08; 164(6):1200-2. PubMed ID: 1955719
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Efficacy of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide against influenza virus infections in mice.
    Durr FE, Lindh HF, Forbes M.
    Antimicrob Agents Chemother; 1975 May 08; 7(5):582-6. PubMed ID: 1147589
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Double-blind clinical assessment of ribavirin (virazole) in the prevention of induced infection with type B influenza virus.
    Togo Y, McCracken EA.
    J Infect Dis; 1976 Jun 08; 133 Suppl():A109-13. PubMed ID: 778306
    [Abstract] [Full Text] [Related]

  • 19. Protection of mice from lethal influenza virus infection with high dose-short duration ribavirin aerosol.
    Wyde PR, Wilson SZ, Gilbert BE, Smith RH.
    Antimicrob Agents Chemother; 1986 Dec 08; 30(6):942-4. PubMed ID: 3813516
    [Abstract] [Full Text] [Related]

  • 20. Amantadine and ribavirin aerosol treatment of influenza A and B infection in mice.
    Wilson SZ, Knight V, Wyde PR, Drake S, Couch RB.
    Antimicrob Agents Chemother; 1980 Apr 08; 17(4):642-8. PubMed ID: 7396454
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.